• DAPT (GSI-IX): Reliable Notch Assay Workflows

  2026-09-16

  Learn how DAPT (GSI-IX), SKU A8200, can improve interpretation of viability, proliferation, and angiogenesis assays by linking γ-secretase inhibition to appropriate controls and readouts. This scenario-based guide covers formulation, protocol optimization, data interpretation, and practical product selection.

• KN-62: Reliable CaMKII Assays

  2026-09-16

  A scenario-based guide to using KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine (SKU A8180) in cell viability, proliferation, and cytotoxicity workflows. It connects biochemical potency, solvent handling, assay controls, and interpretation of calcium-signaling phenotypes.

• H2S Persulfidation and Ferroptosis in NSCLC

  2026-09-15

  A 2024 Molecular Cell study identifies hydrogen sulfide-mediated persulfidation of S-adenosyl homocysteine hydrolase as a metabolic mechanism that sensitizes non-small cell lung cancer cells to ferroptosis. The work connects reduced SAHH activity with lower homocysteine, cysteine, and glutathione availability, especially under cystine-depleted conditions, providing a rationale for combining hydrogen sulfide biology with ferroptosis-based treatment strategies.

• TSPAN18–STIM1 Axis in Prostate Cancer Bone Metastasis

  2026-09-15

  Zhou et al. identify a previously unrecognized mechanism in which TSPAN18 stabilizes STIM1 by limiting TRIM32-mediated ubiquitination, thereby enhancing store-operated calcium entry and prostate cancer bone metastasis. The study connects protein turnover, calcium signaling, metastatic behavior, and clinical disease features, while providing a framework for testing pathway dependency in mechanistic prostate cancer research.

• DAPT (GSI-IX) for Notch Pathway Workflows

  2026-09-14

  DAPT (GSI-IX) gives researchers reversible control over γ-secretase-dependent Notch and APP processing in cell, co-culture, and tumor-model workflows. This guide translates recent thymic epithelial cell programming findings into practical assay designs, dose-finding strategies, and troubleshooting checkpoints.

• SU 5402: Designing Better RTK Signaling Assays

  2026-09-14

  SU 5402 can connect receptor tyrosine kinase engagement with rigorous phenotypic readouts. This guide develops an assay-design framework spanning cancer biology, multiple myeloma research, and carefully bounded neuronal virology applications.

• Prednisolone: Glucocorticoid Signaling Guide

  2026-09-13

  Prednisolone is a synthetic glucocorticoid used to investigate glucocorticoid receptor signaling, inflammation modulation, and immune-cell responses. It is mechanistically distinct from ERAD-engaging chimeras, which use a desonide-derived warhead to promote targeted degradation of transmembrane proteins.

• Phenytoin B2271 for Reliable Cell Assays

  2026-09-12

  This scenario-driven guide explains how Phenytoin (SKU B2271) can support controlled sodium channel modulation research while reducing formulation, solvent, storage, and interpretation errors in cell-based workflows. It integrates product specifications with quantitative evidence from a human paraoxonase-1 study and practical assay controls.

• Fructose Metabolism as a Cancer Therapy Target

  2026-09-11

  The Cancer Letters review presents fructose metabolism as a coordinated cancer-supporting network involving transport, catabolism, signaling, and immune regulation. Its integration of cancer mortality patterns with mechanistic evidence supports pathway-directed therapy while also highlighting the need to distinguish metabolic association from clinically validated causation.

• Phenothiazines Activate Macrophage Antibacterial Defense

  2026-09-11

  The 2025 Frontiers in Immunology study identifies phenothiazines as host-directed agents that strengthen macrophage control of intracellular bacteria through coordinated ROS accumulation, lysosomal activation, and autophagy. Its inhibitor and scavenger experiments support a causal role for these host pathways, while the in vivo perphenazine findings provide an initial bridge from cell models to Salmonella Typhimurium infection.

• Streptavidin – Cy5 in USP42 Apoptosis Research

  2026-09-10

  Learn how Streptavidin – Cy5 converts biotinylated antibodies, probes, and apoptosis markers into sensitive Cy5 readouts for breast cancer experiments. This workflow-focused guide connects the USP42–JNK/p38 findings with practical immunofluorescence, tissue imaging, and flow cytometry design.

• BRCAness and Olaparib Sensitivity in Mesothelioma

  2026-09-10

  Borchert et al. linked homologous recombination repair defects, BAP1 status, and olaparib response in malignant pleural mesothelioma using complementary cell-line experiments and gene-expression profiling of clinical samples. The findings support a broader BRCAness framework for treatment stratification while emphasizing that the proposed cisplatin–olaparib strategy remains an in vitro hypothesis requiring clinical validation.

• Phenothiazines, ROS, and Macrophage Antibacterial Defense

  2026-09-09

  A 2025 Frontiers in Immunology study shows that phenothiazines strengthen macrophage control of intracellular bacteria by increasing reactive oxygen species, lysosomal activity, and autophagy. The work positions perphenazine as a host-directed antibacterial research compound while also highlighting the need to separate class-level immunological effects from dopamine receptor pharmacology and translational efficacy.

• I-BET-762 BET Inhibitor Workflow Guide

  2026-09-09

  I-BET-762 supports selective BET inhibition in inflammation, transcriptional regulation, and ferroptosis-sensitization studies. This practical guide connects validated benchmark conditions with assay design, optimization, and troubleshooting for cancer and inflammatory disease models.

• Cyclodextrin Magnetic Nano-Adsorbents for Uremic Toxins

  2026-09-08

  The reference study develops cyclodextrin-coated magnetic nanoparticles and systematically examines how coating chemistry and exposure conditions influence uremic-toxin adsorption. Its combination of material characterization and quantitative mass spectrometry provides a practical framework for designing retrievable adsorbents aimed at protein-bound toxins that conventional hemodialysis removes inefficiently.

8570 records 4/572 page Previous Next 12345 下5页 Last page